Eliem Therapeutics, Inc. (ELYM) [Rocket]

Date	Name	Title	Type	Security	Shares	Price	Value	Ownership	Reported
03/10/2023	Morisset Valerie	EVP, R&D and CSO	Exercise	Stock Option (Right to Buy)	255.2k	$0.00	$510.4		03/10/2023
03/10/2023	Morisset Valerie	EVP, R&D and CSO	Exercise	Stock Option (Right to Buy)	61.2k	$0.00	$12.2		03/10/2023
05/19/2022	Dunn Judith	Director	Grant	Stock Option (Right To Buy)	10k	$3.46	$34.6k		05/19/2022
05/19/2022	Rosenberg Adam Joseph	Director	Grant	Stock Option (Right To Buy)	10k	$3.46	$34.6k		05/19/2022
05/19/2022	Tate Simon	Director	Grant	Stock Option (Right To Buy)	10k	$3.46	$34.6k		05/19/2022
05/19/2022	Levin Andrew David	Director	Grant	Stock Option (Right to Buy)	10k	$3.46	$34.6k		05/19/2022
05/19/2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Grant	Stock Option (Right to Buy)	10k	$3.46	$34.6k	See footnotes	05/19/2022
05/19/2022	Ratcliffe Liam	Director	Grant	Stock Option (Right To Buy)	10k	$3.46	$34.6k		05/19/2022
05/19/2022	PATTERSON LEONE D	Director	Grant	Stock Option (Right To Buy)	10k	$3.46	$34.6k		05/19/2022
01/27/2022	Bucher James B	EVP and General Counsel	Grant	Stock Option (Right to Buy)	95k	$8.21	$780k		01/27/2022
01/27/2022	Azelby Robert	President & CEO	Grant	Stock Option (Right to Buy)	500k	$8.21	$4.1M		01/27/2022
01/27/2022	Morisset Valerie	EVP, R&D and CSO	Grant	Stock Option (Right to Buy)	170k	$8.21	$1.4M		01/27/2022
01/27/2022	Lavelle Erin	COO & CFO	Grant	Stock Option (Right to Buy)	170k	$8.21	$1.4M		01/27/2022
08/09/2021	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Grant	Stock Option (Right to Buy)	20k	$12.50	$250k	See footnotes	08/09/2021
08/09/2021	Ratcliffe Liam	Director	Grant	Stock Option (Right to Buy)	20k	$12.50	$250k		08/09/2021
08/09/2021	Tate Simon	Director	Grant	Stock Option (Right to Buy)	20k	$12.50	$250k		08/09/2021
08/09/2021	Rosenberg Adam Joseph	Director	Grant	Stock Option (Right to Buy)	20k	$12.50	$250k		08/09/2021
08/09/2021	Levin Andrew David	Director	Grant	Stock Option (Right to Buy)	20k	$12.50	$250k		08/09/2021